Similar Papers

Paper Title
Journal
Date
Author
Comparison of the efficacy and safety of single-agent erlotinib and doublet molecular targeted agents based on erlotinib in advanced non-small cell lung cancer (NSCLC): a systematic review and meta-analysis
Gaofeng Pan ... Shaobo Ke
Targeted Oncology | VOL. 8
Gaofeng Pan, et. al.Gaofeng Pan ... Shaobo Ke
21 Mar 2013
Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial
Joel W Neal ... Suresh S Ramalingam
The Lancet. Oncology | VOL. 17
Joel W Neal, et. al.Joel W Neal ... Suresh S Ramalingam
04 Nov 2016
The efficacy and safety of erlotinib compared with chemotherapy in previously treated NSCLC: A meta-analysis.
...
Mathematical biosciences and engineering : MBE | VOL. 16
, et. al. ...
01 Jan 2019
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non–Small Cell Lung Cancer: A Predictive Marker of Efficacy?
Jordi Remon ... Benjamin Besse
Journal of Thoracic Oncology | VOL. 14
Jordi Remon, et. al.Jordi Remon ... Benjamin Besse
23 Apr 2019
View more papers

More From: BMJ Open

Paper Title
Journal
Date
Author
Efficacy of yeast beta-glucan 1,3/1,6 supplementation on respiratory infection, fatigue, immune markers and gut health among moderate stress adults in Klang Valley of Malaysia: protocol for a randomised, double-blinded, placebo-controlled, parallel-group study
Nur Nadia Mohamad Habibullah ... Kalavathy Ramasamy
BMJ Open | VOL. 15
Nur Nadia Mohamad Habibullah, et. al.Nur Nadia Mohamad Habibullah ... Kalavathy Ramasamy
20 Jan 2025
DepRescribing inapprOpriate Proton Pump InhibiTors (DROPIT): study protocol of a cluster-randomised controlled trial in Swiss primary care
Angela Edith Schulthess-Lisibach ... Enriqueta Vallejo-Yagüe
BMJ Open | VOL. 15
Angela Edith Schulthess-Lisibach, et. al.Angela Edith Schulthess-Lisibach ... Enriqueta Vallejo-Yagüe
20 Jan 2025
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trial
Melanie Varley ... Mark Tuthill
BMJ Open | VOL. 15
Melanie Varley, et. al.Melanie Varley ... Mark Tuthill
20 Jan 2025
Collaboration between ambulance services and primary care: a scoping review protocol
Ann-Therese Hedqvist ... Elin-Sofie Forsgärde
BMJ Open | VOL. 15
Ann-Therese Hedqvist, et. al.Ann-Therese Hedqvist ... Elin-Sofie Forsgärde
15 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.